Nagasaki University · Atomic Bomb Disease Institute

Research keywordsthyroid pathology・thyroid carcinoma・follicular-patterned tumors・spatial immunofluorescence・lenvatinib treatment・radioiodine therapy・malignant progression

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Visualizing malignant progression: in situ CD109-based spatial immunofluorescence assay delineates papillary to anaplastic thyroid carcinoma transformation within the tumor microenvironment. Tomoko Cohen,Keiji Suzuki,Katsuya Matsuda,Hirokazu Kurohama,Yuki Matsuoka,Mayu Ueda,Shinya Satoh,Hisakazu Shindo,Hiroyuki Yamashita,Atsushi Kawakami,Masahiro Nakashima Scientific reports 2026年02月26日2026
• Visualizing malignant progression: in situ CD109-based spatial immunofluorescence assay delineates papillary to anaplastic thyroid carcinoma transformation within the tumor microenvironment. Tomoko Cohen,Keiji Suzuki,Katsuya Matsuda,Hirokazu Kurohama,Yuki Matsuoka,Mayu Ueda,Shinya Satoh,Hisakazu Shindo,Hiroyuki Yamashita,Atsushi Kawakami,Masahiro Nakashima Scientific reports 2026年02月26日2026
• Malignant Potential of Thyroid Follicular Nodular Disease With Solid/Trabecular Components: A Case Report. Mayu Ueda,Katsuya Matsuda,Yusuke Mori,Hirokazu Kurohama,Hiroyuki Mishima,Koh-Ichiro Yoshiura,Norisato Mitsutake,Hisakazu Shindo,Shinya Sato,Hiroyuki Yamashita,Atsushi Kawakami,Masahiro Nakashima Pathology international 75巻12号624頁-628頁 2025年12月2025
• Real-world clinical experience of reduced-dose initiation of lenvatinib in Japanese patients with radioiodine-refractory differentiated thyroid cancer. Yomi Nakashima,Ichiro Horie,Haruka Arimori,Mayu Ueda,Shinpei Nishikido,Yuta Nakamura,Keita Nakaji,Tetsuro Niri,Ayaka Sako,Ai Haraguchi,Toshiyuki Ikeoka,Satoru Akazawa,Akie Moriuchi,Misa Imaizumi,Toshiro Usa,Atsushi Kawakami Endocrine journal 72巻12号1327頁-1337頁 2025年12月01日2025

• 悪性度不明な甲状腺濾胞型腫瘍（FT-UMP）の悪性度評価に資する分子病理学的指標の探索 日本学術振興会 科学研究費助成事業 2026年04月01日 - 2029年03月31日2026

• Official profile